Clinical trial
Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery: A Prospective, Double-Blind Study
NCT00793052 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery: A Prospective, Double-Blind Study
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2008
- Completion date
- December 31, 2009
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.